343 related articles for article (PubMed ID: 38736069)
1. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
2. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
3. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
4. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china.
Guo K; Zhang L; Ye J; Niu X; Jiang H; Gan S; Zhou J; Yang L; Zhou Z
Front Endocrinol (Lausanne); 2022; 13():972785. PubMed ID: 36204109
[TBL] [Abstract][Full Text] [Related]
7. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
8. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
[TBL] [Abstract][Full Text] [Related]
9. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
[No Abstract] [Full Text] [Related]
10. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
[TBL] [Abstract][Full Text] [Related]
11. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
[TBL] [Abstract][Full Text] [Related]
12. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
[TBL] [Abstract][Full Text] [Related]
13. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
Front Public Health; 2022; 10():990281. PubMed ID: 36091534
[TBL] [Abstract][Full Text] [Related]
14. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uhl S; Choure A; Rouse B; Loblack A; Reaven P
J Clin Endocrinol Metab; 2024 Mar; 109(4):1119-1131. PubMed ID: 37987208
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
[No Abstract] [Full Text] [Related]
17. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
[TBL] [Abstract][Full Text] [Related]
19. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
Hay LC; Wilmshurst EG; Fulcher G
Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
[TBL] [Abstract][Full Text] [Related]
20. Flash Glucose Monitoring System facilitates sustainable improvements in glycemic control in patients with type 1 diabetes: A 12-month follow-up study in real life.
Al Hayek AA; Alwin Robert A; Al Dawish MA
Diabetes Metab Syndr; 2022 Oct; 16(10):102620. PubMed ID: 36150328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
